Shopping Cart
- Remove All
- Your shopping cart is currently empty
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist that enhances the affinity of HIF-2alpha and ARNT for transcriptional activation. It alters the Tyr2 conformation of the HIF-2alpha PAS-B structural domain and acts synergistically with inhibitors of the prolyl hydroxylase structural domain (PHD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $44 | In Stock | |
5 mg | $98 | In Stock | |
10 mg | $155 | In Stock | |
25 mg | $262 | In Stock | |
50 mg | $389 | In Stock | |
100 mg | $573 | In Stock | |
500 mg | $1,190 | In Stock | |
1 mL x 10 mM (in DMSO) | $116 | In Stock |
Description | M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist that enhances the affinity of HIF-2alpha and ARNT for transcriptional activation. It alters the Tyr2 conformation of the HIF-2alpha PAS-B structural domain and acts synergistically with inhibitors of the prolyl hydroxylase structural domain (PHD). |
In vitro | M1002 (10 μM; 24 h; 786-O cells) significantly enhances the expression of HIF-2 target genes compared to the control. Additionally, M1002 treatment (5 μM) exhibits synergy with prolyl hydroxylase domain (PHD) inhibitors.[1] |
Molecular Weight | 394.29 |
Formula | C15H8F6N2O2S |
Cas No. | 823830-85-9 |
Smiles | FC(F)(F)C1=CC(=CC(NC2=NS(=O)(=O)C3=CC=CC=C23)=C1)C(F)(F)F |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 10 mg/mL (25.36 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.